Large Cap Biotech Analyst Fye, SMid Cap Biotech Analysts Romero & Shah, along with Dr. Darin Dougherty, Associate Professor of Psychiatry at Harvard Medical School, discuss innovative therapies (relevant companies ITCI, NBIX, XENE, BHVN, NMRA, SAGE) for Major Depressive Disorder (MDD) on an Analyst/Industry conference call to be held on February 23 at 12 pm. Webcast Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ITCI:
- Intra-Cellular Therapies Reports Fourth Quarter And Full-Year 2023 Financial Results And Provides Corporate Update
- Intra-Cellular Therapies Business and Clinical Progress Update
- Intra-Cellular reports Q4 EPS (30c), consensus (44c)
- Notable companies reporting before tomorrow’s open
- Intra-Cellular price target raised to $82 from $76 at Mizuho